A Clinical Study of Tobradex AF

The purpose of this study is to determine the amount of study medication that moves from the front of the eye into the fluid at the front of the inside of the eye...

Date First Received: May 10, 2007

Last Updated: July 28, 2008

Verified by: Alcon Research, July 2008

Clinical Trial Phase: Phase 3 | Start Date: November 2006

Overall Status: Completed

Estimated Enrollment: 900

Brief Summary

Official Title: “A Clinical Study of Tobradex AF”

Condition Keyword(s):

Intervention(s):

The purpose of this study is to determine the amount of study medication that moves from the front of the eye into the fluid at the front of the inside of the eye.

Study Type: Interventional

Study Design: Treatment, Randomized, Double-Blind, Active Control, Parallel Assignment, Bio-equivalence Study

Study Primary Completion Date: February 2007

Intervention(s) in this Clinical Trial

  • Drug: Tobradex AF

Outcome Measures for this Clinical Trial

Primary Measures

  • Concentration of dexamethasone in aqueous humor following a single topical ocular administration
    • Time Frame: Periodic

Secondary Measures

  • Changes in external and internal ocular structures, intraocular pressure, vision and other side effects
    • Time Frame: Periodic

Criteria for Participation in this Clinical Trial

Inclusion Criteria:

  • Adult patients requiring cataract surgery

Exclusion Criteria:

  • Age related

Gender Eligibility for this Clinical Trial: Both

Minimum Age for this Clinical Trial: 18 Years

Maximum Age for this Clinical Trial: N/A

Are Healthy Volunteers Accepted for this Clinical Trial?: No

Clinical Trial Sponsor Information

Lead Sponsor: Alcon Research

Overall Clinical Trial Officials and Contacts

Robert Faulkner Study Director Alcon Research  

Additional Information

Information obtained from ClinicalTrials.gov on August 28, 2008

Link to the current ClinicalTrials.gov record. http://clinicaltrials.gov/show/NCT00473070

Study ID Number: C-06-37

ClinicalTrials.gov Identifier: NCT00473070

Health Authority: United States: Food and Drug Administration

Clinical Trials Authorship and Review

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.